期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

药学服务对低文化水平高龄出院患者的重要性 被引量：6

Importance of Pharmaceutical Care for Elderly Discharged Patients with Low Cultural Level
原文传递
导出
摘要 目的探讨临床药师进行出院用药指导对提高低文化水平出院患者用药安全性、依从性的影响。方法临床药师在临床给患者用药指导中,对内科住院接受治疗的年龄>60岁而文化水平低于小学的出院患者进行了特殊的用药指导,设计了用药记忆信息卡提醒患者用药。结果与结论药师根据患者的用药依从性、病情维持情况及用药知识情况对低文化水平患者出院用药进行指导,有助于提高用药依从性、有效性、安全性,提高患者病情控制效果。 OBJECTIVE To explore the influence of medication guidance from clinical pharmacist on safety and compliance of dischanged patients with low cultural level. METHODS The discharged patients above 60 years old without primary school education received a special medication guidance. Clinical pharmacists designed medication cards for reminding them of administration. RESULTS ＆ Conclusion Base on the elderly discharged patients＇ compliance, maintenance and drug knowledge, the medication cards designed by clinical pharmacists can help to improve effectiveness and safety of disease control.
作者 林淑瑜 甘惠贞 吴晓莉
机构地区 解放军第
出处 《中国现代应用药学》 CAS CSCD 2014年第2期231-233,共3页 Chinese Journal of Modern Applied Pharmacy
关键词 用药指导 低文化水平 出院患者 临床药师 依从性 medication guidance low cultural level discharged patients clinical pharmacist compliance
分类号 R954 [医药卫生—药学]
  • 相关文献

参考文献3

二级参考文献35

  • 1卫生部办公厅.卫生部办公厅关于抗菌药物临床应用管理有关问题的通知[Z].2009.
  • 2Anderson JL, Adams CD, Anman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction [J]. J Am Coll Cardiol,2007,50(7) :e1-e157.
  • 3Bhatt DL, Topol EJ. Clopidogrel added to aspirin versus aspirin alone in sec- ondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Manage- ment, and Avoidance (CHARISMA) trial [ J ]. Am Heart J, 2004,148 : 263- 268.
  • 4Bhatt DI, Scheiman J, Abraham NS, et al. ACCF/ACC/AHA2008 expert con- sensus document on reducing the gastrointestinal risks of anfiplatelet therapy and NSAID use a report of the American Documents [ J]. Circulation,2008,118 (18) :1894-1909.
  • 5Bliden KP, Dichiara J, Tantry US, et al. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutane- ous coronary intervention : is the current antiplatelet therapy adequate [ J ] ? J Am Coll Cardiol,2007,49 (6) :657-666.
  • 6Aschenbrenner DS. Factors that decrease the effectiveness of clopidogrel [ J]. Am J Nurs, 2009,109(6) :66-67.
  • 7Beilelshees AL, Meleod HL. Clopidogrel phamaeogenetics promising steps to- wards patient care [ J ] ? Arterioseler Thromb Vasc Biol, 2006,26 ( 8 ) : 1681- 1683.
  • 8Kim KA, Park PW, Hang SJ, et al. The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mecha- nism for clopidogrel resistance [ J ]. Clin Phannacol Ther, 2008,84 ( 2 ) : 236- 242.
  • 9Vane JR, Botting RM. The mechanism of action of aspirin [J]. Thromb Res, 2003,110:255-258.
  • 10Lee JM, Park S, Shin DJ, et al. Relation of genetic polymorphisms in the cyto- chrome P450 gene with clopidogrel resistance after drug-eluting stent in planta- tion in Koreans [J]. Am J Cardiol, 2009,104(1) :46-51.

共引文献14

同被引文献38

引证文献6

二级引证文献18

中国现代应用药学
2014年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部